Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Intra-Cellular Therapies Inc | 2,000,000 | 2,000,000 | 0 | $167.04M | $263.84M | 8.54% | +$96.80M |
| Guardant Health, Inc.(GH) | 6,419,566 | 5,443,721 | -975,845 | $196.12M | $231.90M | 7.51% | +$35.78M |
| Dynavax Technologies Corp | 17,791,486 | 17,791,486 | 0 | $227.20M | $230.76M | 7.47% | +$3.56M |
| Immunovant, Inc.(IMVT) | 6,000,000 | 9,500,000 | +3,500,000 | $148.62M | $162.35M | 5.26% | +$13.73M |
| Protagonist Therapeutics Inc | 1,000,000 | 3,000,000 | +2,000,000 | $38.60M | $145.08M | 4.70% | +$106.48M |
| Ionis Pharmaceuticals, Inc.(IONS) | 1,933,928 | 4,564,207 | +2,630,279 | $67.61M | $137.70M | 4.46% | +$70.09M |
| Akero Therapeutics Inc | 1,490,000 | 3,210,270 | +1,720,270 | $41.45M | $129.95M | 4.21% | +$88.50M |
| Cytokinetics, Incorporated(CYTK) | 2,500,000 | 3,073,853 | +573,853 | $117.60M | $123.54M | 4.00% | +$5.94M |
| Apellis Pharmaceuticals Inc COM | 4,274,921 | 5,000,000 | +725,079 | $136.41M | $109.35M | 3.54% | -$27.06M |
| Ocular Therapeutix, Inc.(OCUL) | 12,836,282 | 14,294,420 | +1,458,138 | $109.62M | $104.78M | 3.39% | -$4.84M |
| BridgeBio Pharma, Inc.(BBIO) | 819,162 | 2,800,000 | +1,980,838 | $22.48M | $96.80M | 3.13% | +$74.32M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 1,484,266 | +1,484,266 | $0 | $76.25M | 2.47% | +$76.25M |
| Viridian Therapeutics, Inc.(VRDN) | 4,522,741 | 5,380,449 | +857,708 | $86.70M | $72.53M | 2.35% | -$14.17M |
| Structure Therapeutics IncADS | 2,800,000 | 4,100,000 | +1,300,000 | $75.94M | $70.97M | 2.30% | -$4.96M |
| 89bio Inc | 6,478,249 | 9,316,333 | +2,838,084 | $50.66M | $67.73M | 2.19% | +$17.07M |
| Nurix Therapeutics, Inc.(NRIX) | 3,000,000 | 5,500,000 | +2,500,000 | $56.52M | $65.34M | 2.12% | +$8.82M |
| Geron Corporation(GERN) | 4,011,287 | 38,176,251 | +34,164,964 | $14.20M | $60.70M | 1.97% | +$46.50M |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 899,731 | +899,731 | $0 | $57.42M | 1.86% | +$57.42M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 653,513 | 1,350,000 | +696,487 | $27.49M | $48.88M | 1.58% | +$21.39M |
| ANI Pharmaceuticals, Inc.(ANIP) | 649,042 | 700,000 | +50,958 | $35.88M | $46.87M | 1.52% | +$10.99M |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 2,357,702 | +2,357,702 | $0 | $42.77M | 1.38% | +$42.77M |
| Immunocore Holdings plcADS(IMCR) | 519,376 | 1,411,402 | +892,026 | $15.32M | $41.88M | 1.36% | +$26.55M |
| Celldex Therapeutics, Inc.(CLDX) | 1,540,132 | 2,000,000 | +459,868 | $38.92M | $36.30M | 1.18% | -$2.62M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 3,269,126 | +3,269,126 | $0 | $35.99M | 1.17% | +$35.99M |
| Amgen Inc.(AMGN) | 0 | 113,035 | +113,035 | $0 | $35.22M | 1.14% | +$35.22M |
| Xenon Pharmaceuticals Inc.(XENE) | 169,132 | 1,000,000 | +830,868 | $6.63M | $33.55M | 1.09% | +$26.92M |
| Edgewise Therapeutics, Inc.(EWTX) | 710,421 | 1,400,000 | +689,579 | $18.97M | $30.80M | 1.00% | +$11.83M |
| Metsera Inc | 0 | 1,094,408 | +1,094,408 | $0 | $29.79M | 0.96% | +$29.79M |
| Vaxcyte, Inc.(PCVX) | 0 | 750,000 | +750,000 | $0 | $28.32M | 0.92% | +$28.32M |
| Autolus Therapeutics plcADS(AUTL) | 14,218,903 | 17,849,482 | +3,630,579 | $33.41M | $27.67M | 0.90% | -$5.75M |
| Bicara Therapeutics Inc | 2,000,000 | 2,000,000 | 0 | $34.84M | $26.06M | 0.84% | -$8.78M |
| COMPASS Pathways plcADS(CMPS) | 0 | 8,859,648 | +8,859,648 | $0 | $25.34M | 0.82% | +$25.34M |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 1,401,938 | +1,401,938 | $0 | $24.83M | 0.80% | +$24.83M |
| ABIVAX Société AnonymeADS(ABVX) | 3,579,209 | 3,579,209 | 0 | $26.20M | $22.37M | 0.72% | -$3.83M |
| MBX Biosciences, Inc.(MBX) | 3,018,935 | 3,018,935 | 0 | $55.64M | $22.28M | 0.72% | -$33.36M |
| GH Research PLC(GHRS) | 0 | 2,000,000 | +2,000,000 | $0 | $22.06M | 0.71% | +$22.06M |
| Dyne Therapeutics, Inc.(DYN) | 2,000,000 | 2,000,000 | 0 | $47.12M | $20.92M | 0.68% | -$26.20M |
| Engene Holdings Inc COM | 4,557,575 | 4,557,575 | 0 | $30.31M | $20.42M | 0.66% | -$9.89M |
| Insmed Incorporated(INSM) | 0 | 254,751 | +254,751 | $0 | $19.43M | 0.63% | +$19.43M |
| Lakefront Biotherapeutics NVADR(LKFT) | 780,778 | 741,068 | -39,710 | $21.47M | $18.62M | 0.60% | -$2.86M |
| Sage Therapeutics Inc | 0 | 2,038,845 | +2,038,845 | $0 | $16.21M | 0.52% | +$16.21M |
| Terns Pharmaceuticals Inc | 5,576,558 | 5,576,558 | 0 | $30.89M | $15.39M | 0.50% | -$15.50M |
| Korro Bio, Inc.(KRRO) | 874,614 | 874,614 | 0 | $33.30M | $15.23M | 0.49% | -$18.07M |
| Oruka Therapeutics, Inc.(ORKA) | 750,000 | 1,444,709 | +694,709 | $14.54M | $14.82M | 0.48% | +$280.2K |
| Mind Medicine Mindmed Inc | 2,816,594 | 2,500,000 | -316,594 | $19.60M | $14.63M | 0.47% | -$4.98M |
| Upstream Bio, Inc.(UPB) | 1,000,000 | 2,299,567 | +1,299,567 | $16.44M | $14.07M | 0.46% | -$2.37M |
| Olema Pharmaceuticals, Inc.(OLMA) | 3,442,833 | 3,442,833 | 0 | $20.07M | $12.95M | 0.42% | -$7.13M |
| Septerna, Inc.(SEPN) | 1,912,929 | 1,912,929 | 0 | $43.81M | $11.08M | 0.36% | -$32.73M |
| Novavax, Inc.(NVAX) | 2,000,000 | 1,518,182 | -481,818 | $16.08M | $9.73M | 0.32% | -$6.35M |
| Cybin D/B/A Helus Pharma(HELP) | 1,529,987 | 1,529,987 | 0 | $13.49M | $9.70M | 0.31% | -$3.79M |
| Rapt Therapeutics Inc | 6,011,380 | 6,011,380 | 0 | $9.50M | $7.33M | 0.24% | -$2.16M |
| Pliant Therapeutics, Inc.(PLRX) | 5,972,257 | 5,399,681 | -572,576 | $78.65M | $7.29M | 0.24% | -$71.37M |
| Avalo Therapeutics, Inc.(AVTX) | 867,000 | 859,876 | -7,124 | $6.44M | $6.89M | 0.22% | +$445.8K |
| Bicycle Therapeutics PlcADS | 1,276,081 | 767,016 | -509,065 | $17.87M | $6.51M | 0.21% | -$11.35M |
| Beam Therapeutics Inc.(BEAM) | 0 | 315,765 | +315,765 | $0 | $6.17M | 0.20% | +$6.17M |
| Invivyd, Inc.(IVVD) | 10,689,603 | 9,722,254 | -967,349 | $4.74M | $5.88M | 0.19% | +$1.15M |
| Xencor, Inc.(XNCR) | 500,000 | 549,439 | +49,439 | $11.49M | $5.85M | 0.19% | -$5.64M |
| Regulus Therapeutics Inc | 3,262,564 | 3,262,564 | 0 | $5.15M | $5.71M | 0.18% | +$554.6K |
| Inovio Pharmaceuticals, Inc.(INO) | 3,119,162 | 3,119,162 | 0 | $5.71M | $5.08M | 0.16% | -$623.8K |
| Rapport Therapeutics, Inc.(RAPP) | 0 | 457,556 | +457,556 | $0 | $4.59M | 0.15% | +$4.59M |
| Context Therapeutics Inc.(CNTX) | 7,419,355 | 7,419,355 | 0 | $7.79M | $4.54M | 0.15% | -$3.25M |
| Zura Bio LimitedCL A(ZURA) | 3,283,783 | 3,283,783 | 0 | $8.21M | $4.24M | 0.14% | -$3.97M |
| Aligos Therapeutics, Inc.(ALGS) | 244,110 | 444,110 | +200,000 | $9.73M | $3.66M | 0.12% | -$6.06M |
| Spyre Therapeutics, Inc.(SYRE) | 219,015 | 219,015 | 0 | $5.10M | $3.53M | 0.11% | -$1.56M |
| Ikena Oncology Inc | 0 | 2,515,513 | +2,515,513 | $0 | $3.22M | 0.10% | +$3.22M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 523,989 | 523,989 | 0 | $4.51M | $2.25M | 0.07% | -$2.25M |
| Allakos Inc | 5,704,282 | 7,232,701 | +1,528,419 | $6.90M | $1.65M | 0.05% | -$5.26M |
| Neurogene Inc.(NGNE) | 0 | 116,660 | +116,660 | $0 | $1.37M | 0.04% | +$1.37M |
| Climb Bio, Inc.(CLYM) | 1,040,115 | 1,040,115 | 0 | $1.87M | $1.27M | 0.04% | -$603.3K |
| 4d Molecular Therapeutics In | 609,900 | 0 | -609,900 | $3.40M | $0 | — | -$3.40M |
| Centessa Pharmaceuticals PlcADS | 1,350,000 | 0 | -1,350,000 | $22.61M | $0 | — | -$22.61M |
| Genmab A/SADS(GMAB) | 2,000,000 | 0 | -2,000,000 | $41.74M | $0 | — | -$41.74M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 1,450,000 | 0 | -1,450,000 | $49.89M | $0 | — | -$49.89M |
| Nektar Therapeutics(NKTR) | 1,975,998 | 0 | -1,975,998 | $1.84M | $0 | — | -$1.84M |
| Neumora Therapeutics, Inc.(NMRA) | 4,000,000 | 0 | -4,000,000 | $42.40M | $0 | — | -$42.40M |
| Springworks Therapeutics Inc | 3,460,756 | 0 | -3,460,756 | $125.04M | $0 | — | -$125.04M |
| Verona Pharma PlcADS | 850,000 | 0 | -850,000 | $39.47M | $0 | — | -$39.47M |